{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:01:06Z","timestamp":1789912866797,"version":"4.0.1"},"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T00:00:00Z","timestamp":1249603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0006554","type":"journal-article","created":{"date-parts":[[2009,8,6]],"date-time":"2009-08-06T22:16:35Z","timestamp":1249596995000},"page":"e6554","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype"],"prefix":"10.1371","volume":"4","author":[{"given":"Oluf Dimitri","family":"R\u00f8e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endre","family":"Anderssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Helge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Hild","family":"Pettersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Standahl","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Sandeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Haaverstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinar","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,8,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma.","volume":"366","author":"BW Robinson","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.lungcan.2005.03.013","article-title":"Chemotherapy for malignant mesothelioma.","volume":"49","author":"P Baas","year":"2005","journal-title":"Lung Cancer"},{"key":"ref3","first-page":"32","article-title":"Peritoneal mesothelioma: a review.","volume":"9","author":"A Bridda","year":"2007","journal-title":"MedGenMed"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V","article-title":"Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis.","volume":"72","author":"C Boutin","year":"1993","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000109618","article-title":"Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH.","volume":"119","author":"PM Lindholm","year":"2007","journal-title":"Cytogenet Genome Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cancergencyto.2006.04.011","article-title":"Cytogenetic and molecular genetic changes in malignant mesothelioma.","volume":"170","author":"M Musti","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"ref7","article-title":"Malignant pleural mesothelioma: Genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets.","author":"OD Roe","year":"2009","journal-title":"Lung Cancer"},{"key":"ref8","article-title":"Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case-control study.","author":"OD Roe","year":"2008","journal-title":"Lung Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1471-2164-8-147","article-title":"Global gene expression profiling in human lung cells exposed to cobalt.","volume":"8","author":"V Malard","year":"2007","journal-title":"BMC Genomics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0272-5231(21)00334-8","article-title":"Anatomy and physiology of the pleural space.","volume":"6","author":"NS Wang","year":"1985","journal-title":"Clin Chest Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"49820","DOI":"10.1074\/jbc.M209891200","article-title":"PCOLCE2 encodes a functional procollagen C-proteinase enhancer (PCPE2) that is a collagen-binding protein differing in distribution of expression and post-translational modification from the previously described PCPE1.","volume":"277","author":"BM Steiglitz","year":"2002","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10549-005-9089-4","article-title":"Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.","volume":"97","author":"U Langsenlehner","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ejhg.2008.171","article-title":"Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease.","volume":"17","author":"LM FitzGerald","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000386064","article-title":"The design of cancer chemotherapy: metabolic modulation and cellular de novo versus salvage metabolism.","volume":"28","author":"YM Rustum","year":"1980","journal-title":"Antibiot Chemother"},{"key":"ref15","first-page":"1855","article-title":"Decreasing sensitivity to cytotoxic agents parallels increasing tumorigenicity in human fibroblasts.","volume":"51","author":"AR Kinsella","year":"1991","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1535-6108(04)00080-7","article-title":"Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme.","volume":"5","author":"L Rahman","year":"2004","journal-title":"Cancer Cell"},{"key":"ref17","first-page":"1279","article-title":"Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.","volume":"24","author":"PM de Angelis","year":"2004","journal-title":"Int J Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1079\/BJN2001454","article-title":"Pyruvate kinase type M2: a crossroad in the tumor metabolome.","volume":"87","author":"S Mazurek","year":"2002","journal-title":"Br J Nutr"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MEG.0b013e3280102f78","article-title":"Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.","volume":"19","author":"Y Kumar","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref20","first-page":"2320","article-title":"Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.","volume":"61","author":"MT Hartsough","year":"2001","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nature04585","article-title":"Oncogenic activity of Cdc6 through repression of the INK4\/ARF locus.","volume":"440","author":"S Gonzalez","year":"2006","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1196\/annals.1378.073","article-title":"Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer.","volume":"1091","author":"D Reimer","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression.","volume":"25","author":"C Giacinti","year":"2006","journal-title":"Oncogene"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1196\/annals.1395.033","article-title":"CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway.","volume":"1100","author":"HM Kamrul","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000078673","article-title":"MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications.","volume":"71","author":"K Hashimoto","year":"2004","journal-title":"Pathobiology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/1078-0432.249.11.1","article-title":"Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.","volume":"11","author":"A Soling","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11060-006-9284-0","article-title":"Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.","volume":"83","author":"J Xu","year":"2007","journal-title":"J Neurooncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1158\/1078-0432.CCR-04-1029","article-title":"Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis.","volume":"10","author":"SA Ha","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":"Gene expression profiling of primary cutaneous melanoma and clinical outcome.","volume":"98","author":"V Winnepenninckx","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"ref30","article-title":"Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines.","author":"MR Salabat","year":"2008","journal-title":"Mol Carcinog"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2184.2002.00220.x","article-title":"Human glioma PKC-iota and PKC-betaII phosphorylate cyclin-dependent kinase activating kinase during the cell cycle.","volume":"35","author":"M Acevedo-Duncan","year":"2002","journal-title":"Cell Prolif"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.1158\/0008-5472.CAN-05-2372","article-title":"Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer.","volume":"65","author":"RP Regala","year":"2005","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"35567","DOI":"10.1074\/jbc.M607702200","article-title":"Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains.","volume":"281","author":"L Xu","year":"2006","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.molcel.2007.02.003","article-title":"Requirements for Cdk7 in the assembly of Cdk1\/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.","volume":"25","author":"S Larochelle","year":"2007","journal-title":"Mol Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/sj.cdd.4401130","article-title":"Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe.","volume":"9","author":"M Castedo","year":"2002","journal-title":"Cell Death Differ"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/carcin\/bgl168","article-title":"Gambogic acid-induced G2\/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2\/p34 in human gastric carcinoma BGC-823 cells.","volume":"28","author":"J Yu","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.onc.1204199","article-title":"Control of cell cycle progression in human mesothelioma cells treated with gamma interferon.","volume":"20","author":"C Vivo","year":"2001","journal-title":"Oncogene"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nature04151","article-title":"The APC\/C and CBP\/p300 cooperate to regulate transcription and cell-cycle progression.","volume":"438","author":"AS Turnell","year":"2005","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1097-2765(03)00244-2","article-title":"The CCT chaperonin promotes activation of the anaphase-promoting complex through the generation of functional Cdc20.","volume":"12","author":"A Camasses","year":"2003","journal-title":"Mol Cell"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.1072802","article-title":"Orc6 involved in DNA replication, chromosome segregation, and cytokinesis.","volume":"297","author":"SG Prasanth","year":"2002","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1053\/j.seminoncol.2006.04.007","article-title":"Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and others.","volume":"33","author":"SL Warner","year":"2006","journal-title":"Semin Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.onc.1210700","article-title":"High expression of DNA repair pathways is associated with metastasis in melanoma patients.","volume":"27","author":"A Kauffmann","year":"2008","journal-title":"Oncogene"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1101\/sqb.2007.72.004","article-title":"The role of circadian regulation in cancer.","volume":"72","author":"S Gery","year":"2007","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1158\/1078-0432.CCR-06-1730","article-title":"Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer.","volume":"13","author":"S Gery","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/carcin\/bgi075","article-title":"Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.","volume":"26","author":"ST Chen","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1740-3391-6-4","article-title":"Period-2: a tumor suppressor gene in breast cancer.","volume":"6","author":"S Xiang","year":"2008","journal-title":"J Circadian Rhythms"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1210\/me.2007-0521","article-title":"The nuclear hormone receptor family round the clock.","volume":"22","author":"M Teboul","year":"2008","journal-title":"Mol Endocrinol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1128\/MCB.01931-07","article-title":"Evidence for an overlapping role of CLOCK and NPAS2 transcription factors in liver circadian oscillators.","volume":"28","author":"C Bertolucci","year":"2008","journal-title":"Mol Cell Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1158\/1535-7163.MCT-06-0177","article-title":"Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index.","volume":"5","author":"PA Wood","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1073\/pnas.0409897102","article-title":"Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK\/BMAL1 transactivation complex.","volume":"102","author":"VY Gorbacheva","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1677\/JME-07-0001","article-title":"Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen.","volume":"39","author":"S Tozlu-Kara","year":"2007","journal-title":"J Mol Endocrinol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"13677","DOI":"10.1074\/jbc.M400117200","article-title":"Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs.","volume":"279","author":"JE Towne","year":"2004","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkm882","article-title":"KEGG for linking genomes to life and the environment.","volume":"36","author":"M Kanehisa","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/0008-5472.CAN-06-2272","article-title":"Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalpha.","volume":"67","author":"P Briassouli","year":"2007","journal-title":"Cancer Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.","volume":"66","author":"F Lopez-Rios","year":"2006","journal-title":"Cancer Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ctrv.2007.09.005","article-title":"Aurora kinases as targets for cancer therapy.","volume":"34","author":"G Mountzios","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"ref57","first-page":"83","article-title":"The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer.","volume":"25","author":"F Ozdemir","year":"2006","journal-title":"J Exp Clin Cancer Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.","volume":"81","author":"Y Ohta","year":"1999","journal-title":"Br J Cancer"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature02320","article-title":"Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome.","volume":"427","author":"XL Tian","year":"2004","journal-title":"Nature"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1158\/0008-5472.CAN-07-1015","article-title":"Proteasome function is required for DNA damage response and fanconi anemia pathway activation.","volume":"67","author":"C Jacquemont","year":"2007","journal-title":"Cancer Res"},{"key":"ref61","first-page":"2429","article-title":"Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.","volume":"60","author":"Y Ogiso","year":"2000","journal-title":"Cancer Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/gcc.20400","article-title":"Novel microdeletion in the transforming growth factor beta type II receptor gene is associated with giant and large cell variants of nonsmall cell lung carcinoma.","volume":"46","author":"JC Wang","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6874-7-5","article-title":"DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.","volume":"7","author":"T Wei","year":"2007","journal-title":"BMC Womens Health"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.lungcan.2003.08.019","article-title":"A novel approach for assessment of cancer predisposing roles of GSTM1 and GSTT1 genes: use of putatively cancer resistant elderly tumor-free smokers as the referents.","volume":"43","author":"EV Belogubova","year":"2004","journal-title":"Lung Cancer"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.mrfmmm.2007.10.003","article-title":"Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.","volume":"638","author":"M Singh","year":"2008","journal-title":"Mutat Res"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-5793(00)01913-X","article-title":"Differential gene expression in mesothelioma.","volume":"480","author":"BH Rihn","year":"2000","journal-title":"FEBS Lett"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1094>3.0.CO;2-M","article-title":"Gene expression profiling of malignant mesothelioma cell lines: cDNA array study.","volume":"91","author":"E Kettunen","year":"2001","journal-title":"Int J Cancer"},{"key":"ref68","first-page":"3080","article-title":"Gene expression profiling of malignant mesothelioma.","volume":"9","author":"S Singhal","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbadis.2003.10.007","article-title":"Cell protection, resistance and invasiveness of two malignant mesotheliomas as assessed by 10K-microarray.","volume":"1688","author":"S Mohr","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biochi.2003.11.008","article-title":"Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells.","volume":"86","author":"S Mohr","year":"2004","journal-title":"Biochimie"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1378\/chest.125.5.1843","article-title":"Gene expression profiling identifies matriptase overexpression in malignant mesothelioma.","volume":"125","author":"CD Hoang","year":"2004","journal-title":"Chest"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/carcin\/bgh276","article-title":"L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray.","volume":"26","author":"E Kettunen","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/path.1810","article-title":"Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling.","volume":"207","author":"X Sun","year":"2005","journal-title":"J Pathol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1699-0463.1997.tb05099.x","article-title":"Optimization of a battery using nine immunocytochemical variables for distinguishing between epithelial mesothelioma and adenocarcinoma.","volume":"105","author":"A Dejmek","year":"1997","journal-title":"APMIS"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2007.08.028","article-title":"Mesothelin targeted cancer immunotherapy.","volume":"44","author":"R Hassan","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/S0046-8177(03)00339-3","article-title":"Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples.","volume":"34","author":"A Lugli","year":"2003","journal-title":"Hum Pathol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/thx.54.8.707","article-title":"Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions.","volume":"54","author":"DR Thickett","year":"1999","journal-title":"Thorax"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0092-8674(01)00328-2","article-title":"Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell.","volume":"105","author":"DS Krause","year":"2001","journal-title":"Cell"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1513\/pats.200512-133TK","article-title":"The extrapulmonary origin of fibroblasts: stem\/progenitor cells and beyond.","volume":"3","author":"VN Lama","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"ref80","first-page":"35","article-title":"Isolation of stromal stem cells from human adipose tissue.","volume":"325","author":"AC Boquest","year":"2006","journal-title":"Methods Mol Biol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/0008-5472.CAN-06-3700","article-title":"Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.","volume":"67","author":"C Lu","year":"2007","journal-title":"Cancer Res"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/gcc.20475","article-title":"Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines.","volume":"46","author":"C Zanazzi","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/bioinformatics\/btf877","article-title":"Identifying differentially expressed genes using false discovery rate controlling procedures.","volume":"19","author":"A Reiner","year":"2003","journal-title":"Bioinformatics"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing.","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.","volume":"25","author":"M Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1471-2105-8-346","article-title":"A framework for significance analysis of gene expression data using dimension reduction methods.","volume":"8","author":"L Gidskehaug","year":"2007","journal-title":"BMC Bioinformatics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0006554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:47:02Z","timestamp":1739296022000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0006554"}},"subtitle":[],"editor":[{"given":"Per","family":"Westermark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,8,7]]},"references-count":86,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2009,8,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0006554","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,7]]}}}